BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

266 related articles for article (PubMed ID: 34844624)

  • 21. Longitudinal study of COVID-19 stay-at-home orders' impact on deaths of despair in the United States, January 2019 to December 2020.
    Kaslow NJ; Lewis PC; Cheong YF; Yount KM
    J Public Health (Oxf); 2023 Aug; 45(3):710-713. PubMed ID: 37132026
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Low awareness of risk mitigation prescribing in response to dual crises of COVID-19 and overdose deaths among people who use unregulated drugs in Vancouver, Canada.
    Moshkforoush M; DeBeck K; Brar R; Fairbairn N; Cui Z; Milloy MJ; Buxton J; Oldenburger T; McLellan W; Kendall P; Sedgemore K; Wilson D; Kerr T; Hayashi K
    Harm Reduct J; 2022 May; 19(1):50. PubMed ID: 35614440
    [TBL] [Abstract][Full Text] [Related]  

  • 23. People who use drugs' prioritization of regulation amid decriminalization reforms in British Columbia, Canada: A qualitative study.
    Xavier JC; McDermid J; Buxton J; Henderson I; Streukens A; Lamb J; Greer A
    Int J Drug Policy; 2024 Mar; 125():104354. PubMed ID: 38402802
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Impact of the COVID-19 pandemic on opioid overdose and other adverse events in the USA and Canada: a systematic review.
    Simha S; Ahmed Y; Brummett CM; Waljee JF; Englesbe MJ; Bicket MC
    Reg Anesth Pain Med; 2024 May; 49(5):361-362. PubMed ID: 36427903
    [No Abstract]   [Full Text] [Related]  

  • 25. Forecasted and Observed Drug Overdose Deaths in the US During the COVID-19 Pandemic in 2020.
    Cartus AR; Li Y; Macmadu A; Goedel WC; Allen B; Cerdá M; Marshall BDL
    JAMA Netw Open; 2022 Mar; 5(3):e223418. PubMed ID: 35311967
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Ambulance Services Attendance for Mental Health and Overdose Before and During COVID-19 in Canada and the United Kingdom: Interrupted Time Series Study.
    Law G; Cooper R; Pirrie M; Ferron R; McLeod B; Spaight R; Siriwardena AN; Agarwal G;
    JMIR Public Health Surveill; 2024 May; 10():e46029. PubMed ID: 38728683
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Bridging the Gap in Harm Reduction Using Mobile Overdose Response Services (MORS) in the Context of the COVID-19 Pandemic: A Qualitative Study.
    Seo B; Rioux W; Rider N; Teare A; Jones S; Taplay P; Ghosh SM
    J Urban Health; 2024 Apr; 101(2):252-261. PubMed ID: 38514599
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Excess Fatal Overdoses in the United States During the COVID-19 Pandemic by Geography and Substance Type: March 2020-August 2021.
    Chandra J; Charpignon ML; Bhaskar A; Therriault A; Chen YH; Mooney A; Dahleh MA; Kiang MV; Dominici F
    Am J Public Health; 2024 Jun; 114(6):599-609. PubMed ID: 38718338
    [No Abstract]   [Full Text] [Related]  

  • 29. During the COVID-19 Pandemic, Opioid Overdose Deaths Revert to Previous Record Levels in Ohio.
    Vieson J; Yeh AB; Lan Q; Sprague JE
    J Addict Med; 2022 Mar-Apr 01; 16(2):e118-e122. PubMed ID: 34172625
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Receipt of Telehealth Services, Receipt and Retention of Medications for Opioid Use Disorder, and Medically Treated Overdose Among Medicare Beneficiaries Before and During the COVID-19 Pandemic.
    Jones CM; Shoff C; Hodges K; Blanco C; Losby JL; Ling SM; Compton WM
    JAMA Psychiatry; 2022 Oct; 79(10):981-992. PubMed ID: 36044198
    [TBL] [Abstract][Full Text] [Related]  

  • 31. The Use of Cremation Data for Timely Mortality Surveillance During the COVID-19 Pandemic in Ontario, Canada: Validation Study.
    Postill G; Murray R; Wilton AS; Wells RA; Sirbu R; Daley MJ; Rosella L
    JMIR Public Health Surveill; 2022 Feb; 8(2):e32426. PubMed ID: 35038302
    [TBL] [Abstract][Full Text] [Related]  

  • 32. New Psychoactive Substances and receding COVID-19 pandemic: really going back to "normal"?
    Napoletano S; Basile G; Lo Faro AF; Negro F
    Acta Biomed; 2022 May; 93(2):e2022186. PubMed ID: 35545997
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Geographic variations in opioid overdose patterns in Pennsylvania during the COVID-19 pandemic.
    King B; Holmes LM; Rishworth A; Patel R
    Health Place; 2023 Jan; 79():102938. PubMed ID: 36549235
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Suicide and drug toxicity mortality in the first year of the COVID-19 pandemic: use of medical examiner data for public health in Nova Scotia.
    Schleihauf E; Bowes MJ
    Health Promot Chronic Dis Prev Can; 2022 Feb; 42(2):60-67. PubMed ID: 34757897
    [TBL] [Abstract][Full Text] [Related]  

  • 35. COVID-19 pandemic responses of Canada and United States in first 6 months: A comparative analysis.
    Combden S; Forward A; Sarkar A
    Int J Health Plann Manage; 2022 Jan; 37(1):50-65. PubMed ID: 34514624
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Changes in substance supply and use characteristics among people who use drugs (PWUD) during the COVID-19 global pandemic: A national qualitative assessment in Canada.
    Ali F; Russell C; Nafeh F; Rehm J; LeBlanc S; Elton-Marshall T
    Int J Drug Policy; 2021 Jul; 93():103237. PubMed ID: 33893026
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Brief Report: The Impact of COVID-19 on Emergency Department Overdose Diagnoses and County Overdose Deaths.
    Shreffler J; Shoff H; Thomas JJ; Huecker M
    Am J Addict; 2021 Jul; 30(4):330-333. PubMed ID: 33738889
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Evaluation of risk mitigation measures for people with substance use disorders to address the dual public health crises of COVID-19 and overdose in British Columbia: a mixed-method study protocol.
    Nosyk B; Slaunwhite A; Urbanoski K; Hongdilokkul N; Palis H; Lock K; Min JE; Zhao B; Card KG; Barker B; Meilleur L; Burmeister C; Thomson E; Beck-McGreevy P; Pauly B
    BMJ Open; 2021 Jun; 11(6):e048353. PubMed ID: 34108170
    [TBL] [Abstract][Full Text] [Related]  

  • 39. The Impact of the Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) Pandemic on Substance Use in the United States.
    Ross JA; Malone PK; Levy S
    Clin Infect Dis; 2022 Aug; 75(Suppl 1):S81-S85. PubMed ID: 35476024
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Factors associated with perceived decline in the quality of drugs during the COVID-19 pandemic: Evidence from community-recruited cohorts of people who use drugs in Vancouver, Canada.
    McAdam E; Hayashi K; Dong H; Cui Z; Sedgemore KO; Dietze P; Phillips P; Wilson D; Milloy MJ; DeBeck K
    Drug Alcohol Depend; 2022 Jul; 236():109471. PubMed ID: 35489180
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 14.